Predictive Value of the Water Drinking Test and the Risk of Glaucomatous Visual Field Progression

Imagem de Miniatura
Arquivos
art_MORAES_Predictive_Value_of_the_Water_Drinking_Test_and_2017.PDF (172.42 KB)
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2017
Editora
LIPPINCOTT WILLIAMS & WILKINS
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
SAKATA, Lisandro M.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF GLAUCOMA, v.26, n.9, p.767-773, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: The purpose of this is to test the hypothesis the intraocular pressure (IOP) peaks during a stress test [the water drinking test (WDT)] can estimate the risk of future visual field progression in treated primary open- angle glaucoma (POAG) patients. Patients and Methods: Design: Prospective, longitudinal study. Setting: Clinical practice. Study population: Treated POAG patients whose IOP was <= 18mmHg and who had no IOPlowering interventions between the date of the WDT and the last eligible visual field. Intervention: At baseline examination, patients underwent the WDT and were then followed at regular intervals with office-based IOP measurements and visual field testing. Main outcome measure: Cox-proportional hazards survival analysis testing the predictive value of IOP peaks during the WDT versus IOP measurements during office hours on visual field progression. Results: A total of 144 eyes of 96 patients with baseline visual field damage ranging from mild to severe followed for a mean of 28 months were analyzed. In the multivariable analysis adjusting for potential confounders, higher IOP peaks during the WDT were predictive of future visual field progression (hazard ratio=1.11; 95% confidence interval, 1.02 to 1.21; P= 0.013). The average and peak IOP during office hours over the same follow-up period were not significantly associated with progression (P= 0.651 and 0.569, respectively). Conclusions: IOP peaks detected with the WDT were predictive of future visual field progression in a treated POAG population. This stress test could be a useful tool for risk assessment in daily practice.
Palavras-chave
glaucoma, water drinking test, visual fields, progression, risk factors
URI
https://observatorio.fm.usp.br/handle/OPI/21948
Referências
  1. Anderson DR, 1992, AUTOMATED STATIC PER
  2. Anderson SD, 1996, J AEROSOL MED, V9, P95, DOI 10.1089/jam.1996.9.95
  3. Asrani S, 2000, J GLAUCOMA, V9, P134
  4. Association WG, 2016, CONS 10 DIAGN PRIM O
  5. Babic M, 2015, CLIN EXP OPHTHALMOL, V43, P228, DOI 10.1111/ceo.12434
  6. Bengtsson B, 2005, GRAEF ARCH CLIN EXP, V243, P513, DOI 10.1007/s00417-004-1103-8
  7. Blumberg D, 2015, PROG BRAIN RES, V221, P81, DOI 10.1016/bs.pbr.2015.04.007
  8. BLUMENTHAL DS, 1981, AM J MED, V70, P1005, DOI 10.1016/0002-9343(81)90850-0
  9. Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1
  10. Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030
  11. Chauhan BC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1249, DOI 10.1001/archophthalmol.2010.196
  12. Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615
  13. Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006
  14. CURRIE PJ, 1983, AM J CARDIOL, V52, P927, DOI 10.1016/0002-9149(83)90507-6
  15. De Moraes CG, 2016, OPHTHALMOLOGY, V123, P744, DOI 10.1016/j.ophtha.2015.11.020
  16. De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015
  17. De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72
  18. De Moraes CGV, 2009, CLIN EXP OPHTHALMOL, V37, P270, DOI 10.1111/j.1442-9071.2009.02003.x
  19. Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3
  20. Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5
  21. Goldberg I, 2010, AM J OPHTHALMOL, V150, P447, DOI 10.1016/j.ajo.2010.06.035
  22. Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
  23. Hatanaka M, 2016, J GLAUCOMA, V25, P914, DOI 10.1097/IJG.0000000000000519
  24. Hatanaka M, 2008, J GLAUCOMA, V17, P674, DOI 10.1097/IJG.0b013e318168f008
  25. Investigators A., 2000, AM J OPHTHALMOL, V130, P429
  26. Kerr NM, 2016, J GLAUCOMA, V25, P727, DOI 10.1097/IJG.0000000000000512
  27. Kumar RS, 2008, CLIN EXP OPHTHALMOL, V36, P312, DOI 10.1111/j.1442-9071.2008.01765.x
  28. Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016
  29. Mansouri K, 2008, BRIT J OPHTHALMOL, V92, P332, DOI 10.1136/bjo.2007.123042
  30. Medeiros FA, 2002, J OCUL PHARMACOL TH, V18, P489, DOI 10.1089/108076802321021036
  31. MILLER D, 1964, AM J OPHTHALMOL, V58, P243
  32. Mocan MC, 2016, J GLAUCOMA, V25, P301, DOI 10.1097/IJG.0000000000000223
  33. Morrow DA, 2010, CIRCULATION, V121, P2681, DOI 10.1161/CIRCULATIONAHA.109.852749
  34. Musch DC, 2011, OPHTHALMOLOGY, V118, P1766, DOI 10.1016/j.ophtha.2011.01.047
  35. Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051
  36. Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017
  37. Ozyol E, 2016, ACTA OPHTHALMOL, V94, pE795, DOI 10.1111/aos.13132
  38. Ozyol P, 2016, CLIN OPHTHALMOL, V10, P1351, DOI 10.2147/OPTH.S108456
  39. Ritch R, 2008, PROG BRAIN RES, V173, P211, DOI 10.1016/S0079-6123(08)01115-1
  40. Rivera JL, 2008, CURR OPIN OPHTHALMOL, V19, P102, DOI 10.1097/ICU.0b013e3282f493b3
  41. Rossi GCM, 2011, EUR J OPHTHALMOL, V21, P410, DOI 10.5301/EJO.2010.6112
  42. ROTH JA, 1974, BRIT J OPHTHALMOL, V58, P55, DOI 10.1136/bjo.58.1.55
  43. Schwartz Gail F, 2005, Curr Opin Ophthalmol, V16, P114, DOI 10.1097/01.icu.0000156139.05323.26
  44. Susanna R, 2006, INVEST OPHTH VIS SCI, V47, P641, DOI 10.1167/iovs.04-0268
  45. Susanna R, 2005, BRIT J OPHTHALMOL, V89, P1298, DOI 10.1136/bjo.2005.070649
  46. Susanna R, 2004, CLIN THER, V26, P755
  47. Susanna R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.1
  48. Tsai JC, 2009, OPHTHALMOLOGY, V116, pS30, DOI 10.1016/j.ophtha.2009.06.024
  49. Vasconcelos-Moraes CG, 2008, CLINICS, V63, P433, DOI 10.1590/S1807-59322008000400004
  50. Waisbourd M, 2016, CLIN EXP OPHTHALMOL, V44, P89, DOI 10.1111/ceo.12639
  51. Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350
  52. Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0
  53. Weinreb RN, 2011, 8 WORLD GLAUC ASS
  54. YOSHIKAWA K, 1993, ACTA OPHTHALMOL, V71, P463

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOF
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/33